1、012 9365 z 30 HANAI T，SHIAKI M，WATANABE S，et al Sarcopeniapredicts minimal hepatic encephalopathy in patients withliver cirrhosisJ Hepatol es，2017，47(13):1359 1367 DOI:101111/hepr12873 31 NADELLI S，IGGIO O，GIOIA S，et al isk factors forhepatic encephalopathy and mortality in cirrhosis:The roleof cogn
2、itive impairment，muscle alterations and shuntsJ Dig Liver Dis，2022，54(8):1060 1065 DOI:101016/j dld202112015 32 HANAI T，NISHIMUA K，MIWA T，et al Usefulness of nu-tritional therapy recommended in the Japanese Society ofGastroenterology/Japan Society of Hepatology evidence based clinical practice guide
3、lines for liver cirrhosis 2020 J J Gastroenterol，2021，56(10):928 937 DOI:101007/s00535 021 01821 z 33 NADELLI S，GIOIA S，PASQUALE C，et al Cognitiveimpairment predicts the occurrence of hepatic encepha-lopathy after transjugular intrahepatic portosystemic shuntJ Am J Gastroenterol，2016，111(4):523 528D
4、OI:101038/ajg201629 34 CAI W，LIN H，QI，et al Psoas muscle density predictsoccurrences of hepatic encephalopathy in patients receiv-ing transjugular intrahepatic portosystemic shunts within 1yearJ Cardiovasc Intervent adiol，2022，45(1):93 101 DOI:101007/s00270 021 02961 8 35 GIOIA S，IDOLA L，CISTOFAO L，
5、et alTheimprovement in body composition including subcuta-neous and visceral fat reduces ammonia and hepatic en-cephalopathy after transjugular intrahepatic portosystemicshuntJ Liver Int，2021，41(12):2965 2973 DOI:101111/liv15060 36 YANG C，ZHU X，LIU J，et al Development and validation ofprognostic mod
6、els to estimate the risk of overt hepatic en-cephalopathy after TIPS creation:A multicenter studyJ Clin Transl Gastroenterol，2022，13(3):e00461 DOI:1014309/ctg0000000000000461 37 ZENG X，SHI ZW，YU JJ，et al Sarcopenia as a prognosticpredictor of liver cirrhosis:a multicentre study in China J JCachexia
7、Sarcopenia Muscle，2021，12(6):1948 1958DOI:101002/jcsm12797 38 KUMA A，DAVULUI G，SILVA NE，et al Ammonialowering reverses sarcopenia of cirrhosis by restoring skel-etal muscle proteostasisJ Hepatology，2017，65(6):2045 2058 DOI:101002/hep29107 39 EBADI M，TSIEN C，BHANJI A，et al Skeletal musclepathological
8、 fat infiltration(myosteatosis)is associatedwith higher mortality in patients with cirrhosisJ Cells，2022，11(8):1345 DOI:103390/cells11081345 40 MIWA T，HANAI T，NISHIMUA K，et al Survival benefitof l carnitine supplementation in patients with cirrhosisJ JPEN J Parenter Enteral Nutr，2022，46(6):1326 1334
9、 DOI:101002/jpen2386 41 IACOB S，MINA V，MANDEA M，et al Assessment of sar-copenia related quality of life using SarQoLquestionnairein patients with liver cirrhosisJ Front Nutr，2022，9:774044 DOI:103389/fnut2022774044收稿日期:2022 07 23;录用日期:2022 08 25本文编辑:林姣引证本文:ZHU YJ，LI W，ZHAO SS esearch advances inthe a
10、ssociation between sarcopenia and hepatic encepha-lopathy in patients with liver cirrhosisJ J Clin Hepatol，2023，39(3):671 676朱伊静，李伟，赵守松 肝硬化患者肌肉减少症与肝性脑病的关系J 临床肝胆病杂志，2023，39(3):671 676读者作者编者临床肝胆病杂志 推荐使用的规范医学名词术语(后者为规范术语)几率概率爆发暴发人蓄共患人畜共患粘膜黏膜标记物标志物血管加压素血管升压素黏连粘连适应症适应证红细胞压积红细胞比容酒精乙醇禁忌症禁忌证革兰氏阴性菌革兰阴性菌食道食管侧枝循环侧支循环抗菌素抗生素676临床肝胆病杂志第39 卷第3 期2023 年3 月J Clin Hepatol，Vol39 No3，Mar2023
